GSK Says BLENREP Gets EU Approval To Treat Relapsed And Refractory Multiple Myeloma
GSK Says BLENREP Gets EU Approval To Treat Relapsed And …
Aug 27, 2020
nasdaq.com
GSK: Japan Approves Blenrep Combinations To Treat Relapsed/refractory Multiple Myeloma In Adults
GSK: Japan Approves Blenrep Combinations To Treat Relapsed/r…
Jul 25, 2018
finanznachrichten.de
Boost for GSK as blood cancer drug Blenrep hits key trial goal
Boost for GSK as blood cancer drug Blenrep hits key trial goal
Nov 27, 2023
thisismoney.co.uk
Blenrep (belantamab mafodotin) is an antibody drug conjugate—it hooks onto myeloma cells and delivers a toxic ‘backpack’ to destroy them.’ New data show adding Blenrep to standard treatments improves outcomes, especially in high-risk myeloma. #AskTheIMF | International Myeloma Foundation
1:07
Blenrep (belantamab mafodotin) is an antibody drug conjugate—it ho…
4.2K views1 month ago
FacebookInternational Myeloma Foundation
GSK Plc: Confident In Benefit/risk Profile Of Blenrep
GSK Plc: Confident In Benefit/risk Profile Of Blenrep
2 months ago
finanznachrichten.de
FDA Committee Votes Against GSK Blood Cancer Drug Blenrep
FDA Committee Votes Against GSK Blood Cancer Drug Blenrep
2 months ago
wsj.com
Blenrep (belantamab mafadotin) for multiple myeloma — Dr. Jesus Berdeja | MCRT Webcast August 22
11:39
Blenrep (belantamab mafadotin) for multiple myeloma — Dr. Jesus Ber…
1.3K viewsAug 25, 2020
YouTubeHealthTree Foundation
1:27
Early relapse myeloma is an exciting area of new research — including …
9K views1 month ago
FacebookInternational Myeloma Foundation
4:57
Blenrep_FULL
5 months ago
VimeoSyneos Health Learning Solutions
GSK submits multiple myeloma treatment for approval to the US r…
2 views10 months ago
proactiveinvestors.com
18:54
Multiple Myeloma 101: Diagnosis, Prognosis, and Risk
4.5K viewsMay 9, 2024
YouTubeDana-Farber Cancer Institute
Behind the FDA Approvals of BCMA-Directed Therapies for Multiple My…
Sep 16, 2022
targetedonc.com
2:11
Belantamab Mafodotin for Multiple Myeloma | NEJM
2K viewsAug 1, 2024
YouTubeNEJM Group
GSK blood cancer drug Blenrep fails to beat rival treatments in tests
Nov 22, 2022
thisismoney.co.uk
Dr. Martin on the Safety Profile of Belantamab Mafodotin in R/R Multi…
3 weeks ago
onclive.com
0:49
Many patients, especially those not eligible for CAR T, could benefit fr…
1.1K views1 month ago
YouTubeInternational Myeloma Foundation
Management of belantamab mafodotin-associated corneal eve…
May 26, 2021
nature.com
GSK shares fall as blood cancer drug trial fails to meet its goal
Nov 7, 2022
thisismoney.co.uk
13:27
Patient & Family Seminar 2024 | Advancements in Myeloma Treatm…
2.3K viewsAug 21, 2024
YouTubeInternational Myeloma Foundation
3:40
Blenrep_ CUTDOWN Logo
1 month ago
VimeoSyneos Health Learning Solutions
2:18
2 minutes pour comprendre - Soins de support & myélome multiple
1.7K viewsSep 5, 2022
YouTubeSanofi en France
Dr. Callander on the Expanding Role of Belantamab Mafodotin in Multip…
Jan 28, 2021
onclive.com
9:38
Western Blotting Protocol
184.1K viewsMay 1, 2013
YouTubeCell Signaling Technology, Inc.
Establishing a Treatment Plan for Triple-Class Refractory Myeloma | …
1 week ago
onclive.com
Dr. Finn on the Utility of Belantamab Mafodotin in Late Relapsed Multipl…
Jan 17, 2022
onclive.com
1:02:24
FAQs on Smoldering Multiple Myeloma: Understanding and Man…
1.1K views7 months ago
YouTubeMultiple Myeloma Research Foundation - MMRF
1:41
What are the symptoms of multiple myeloma? Rafael Fonseca, M.D., …
66.2K viewsJul 27, 2023
YouTubeMayo Clinic
1:53
Ensayos clínicos: la visión de enfermería | Ruta AE Mieloma Múlt…
12.2K views4 months ago
YouTubeJanssen Contigo
9:26
Mieloma multiple, llegando a su diagnóstico 👨‍⚕️
20.1K viewsApr 17, 2024
YouTubeDr Semio
24:30
S1 Episode 5: Multiple Myeloma Therapies: A Glimpse Into the Fut…
1 month ago
YouTubeMedscape
See more videos
Static thumbnail place holder